GLP-1 in Singapore: what it is, what it costs, and how to start

GLP-1 medication is a prescription-only medicine in Singapore that turns down appetite. At GetLean, Dr Quek prescribes it where clinically appropriate, inside a doctor-led programme: S$20 consult, Oral GLP-1 programme from S$288 a month (S$388 depending on dose), Injectable GLP-1 programme from S$488 a month (S$788 depending on dose, S$1,088 at the max dose), medication included. Book your consult.

Live video consultation · SMC-registered doctor · HCSA licence R/26M2469/MDS/001/262

Updated

Book my S$20 consult

Dr Quek confirms suitability at your consultation.

What is GLP-1?

GLP-1 is glucagon-like peptide-1, a hormone your gut releases after you eat, and a GLP-1 medication is a prescription medicine that activates the receptor for it. In weight management its main effect is on appetite (Drucker 2018). The medicines registered in Singapore for weight management include tirzepatide and semaglutide injection (Singapore NDF; Singapore NDF); tirzepatide also acts at the receptor for a second gut hormone, GIP, which is why it is called a dual agonist (prescribing information). In Singapore, tirzepatide is registered as Mounjaro, and semaglutide injection as Wegovy for weight management and as Ozempic for type 2 diabetes.

Both are injections taken once a week, at any time of day, with or without meals (semaglutide label; tirzepatide label). The only GLP-1 tablet on Singapore's register, oral semaglutide (sold as Rybelsus), is registered here for type 2 diabetes (Singapore NDF). How GLP-1 medications work explains the mechanism, and What GLP-1 medication does, and what it does not covers the whole class. Weight loss injections in Singapore compares the injections registered here.

How do GLP-1 drugs help you lose weight?

Mainly by turning down appetite, so people eat less. Measured in people, intake at a single test lunch was 35% lower on semaglutide 2.4 mg than on placebo at week 20 (Friedrichsen 2021): one test meal, not tracked daily eating.

In the large trials, adults on semaglutide 2.4 mg lost 14.9% of their body weight on average over 68 weeks, against 2.4% on placebo (STEP 1, Wilding 2021), and adults on tirzepatide 15 mg lost 20.9% over 72 weeks, against 3.1% on placebo (SURMOUNT-1, Jastreboff 2022). Everyone in those trials also had a lifestyle programme, the placebo groups lost weight too, and individual results vary and are not guaranteed.

The medication starts it, daily WhatsApp coaching builds the habits, and Dr Quek plans the taper, so the result holds.

Is GLP-1 legal in Singapore?

Yes, as a prescription medicine. Every registered semaglutide, tirzepatide and liraglutide product here is classified Prescription Only (HSA register), and MOH has stated in Parliament that GLP-1 medicines may only be dispensed by a registered doctor or a licensed retail pharmacy against a valid prescription (MOH 2024).

Seeing a doctor online is legal too, through a clinic licensed for remote care. A first-time patient must be seen by real-time two-way video (OMS Regulations 2023), and the joint regulator circular states that medicines should not be prescribed just by getting a patient to fill in a questionnaire (Circular 87/2024). GetLean Clinic is licensed by Singapore's Ministry of Health under the Healthcare Services Act 2020, for outpatient medical service delivered remotely, and consultations are with Dr Quek, who is registered with the Singapore Medical Council. Telehealth GLP-1 treatment: the rules in Singapore sets out each rule. For the consultation steps, read Can an online doctor in Singapore prescribe GLP-1 for weight loss?.

Can I get GLP-1 without going to a doctor?

No. GLP-1 medicines are prescription-only in Singapore, and a prescription is valid here only if it is signed by a doctor registered under the Medical Registration Act 1997 (Therapeutic Products Regulations 2016). HSA has received reports of people hospitalised with severe vomiting after taking GLP-1 medicines without a prescription and medical supervision, from overseas or online (HSA 2026), and it has found weight-loss products sold online to contain sibutramine, a drug disallowed for sale in Singapore since 2010 (HSA).

You do not have to go to a clinic, though: at GetLean the doctor comes to you, by live video from home, and where a prescription is issued, the medication is delivered to your door. Compounded semaglutide and Telegram sellers: the real risk covers the channels to avoid.

How much does GLP-1 cost in Singapore?

At GetLean: S$20 consult, Oral GLP-1 programme from S$288 a month (S$388 depending on dose), Injectable GLP-1 programme from S$488 a month (S$788 depending on dose, S$1,088 at the max dose). The monthly price depends on the medication and dose Dr Quek prescribes, and it includes the medication.

The monthly fee covers doctor video consultations and ongoing medical oversight, the GLP-1 medication as prescribed and delivered, a personalised nutrition and daily activity plan, and WhatsApp support from the care team, 9am to 9pm every day, Singapore time. Outside those hours an urgent symptom does not wait for a reply: go to an emergency department, or call 995 if it is an emergency.

You get your S$20 back if Dr Quek decides GLP-1 medication is not right for you. Billing is monthly, and there is no lock-in: the programme can be cancelled at any time. After the taper, the daily WhatsApp coaching and a monthly review consultation with Dr Quek can continue for S$88 a month, without medication. It is optional.

What MediSave and insurance cover for weight-loss treatment is set out in Does MediSave or insurance cover GLP-1 for weight loss in Singapore?, and the pricing page has the details.

Will a doctor prescribe GLP-1 for weight loss?

Yes, where it is clinically appropriate: a doctor in Singapore assesses you first, and a consultation does not guarantee a prescription. At GetLean that doctor is Dr Quek, and it works in five steps, all from home:

  1. Book your consult.
  2. A 30-minute video consultation with Dr Quek. It is a live video call on Google Meet. Dr Quek reviews your history and goals and decides whether the programme is suitable for you. If he decides medication is not right for you, we refund your consultation fee in full.
  3. Prescription and delivery. Where a prescription is issued, the medication is delivered discreetly to your door, and first delivery is typically the next working day after your consultation.
  4. Daily coaching on WhatsApp. A personalised nutrition and daily activity plan, and daily WhatsApp coaching: send a photo or description of a meal and the assistant estimates the calories and protein and shows what is left for the day. The assistant gives no medical, nutrition or dosing advice; anything clinical goes to Dr Quek.
  5. Monthly reviews, and a planned exit. Dr Quek reviews how it is going every month, and dose changes are made at that check-in, towards the lowest effective dose. The plan for coming off, the GetLean GLP-1 Taper Plan, is set from your first consultation.

Our criteria are a BMI of 25 or more. Anyone can book the first consultation and Dr Quek decides there whether a GLP-1 medication suits you. We explain how the BMI figures work in eligibility and BMI thresholds for Asian adults. You must be at least 18 years old and resident in Singapore. New to GLP-1 and already on it with another doctor are both welcome: tell us your medication and dose, and where it is clinically appropriate, an existing dose can typically be continued rather than restarted (how switching works).

Want to see an online doctor about GLP-1? Book your consult for a S$20 video consultation with Dr Quek. Book your consult

Is GLP-1 the same as Ozempic?

No: GLP-1 is a class of medicines, not one medicine. Ozempic is one of them: the lower-dose semaglutide injection, registered in Singapore for type 2 diabetes only, with no registered weight-management indication here (NDF). The same molecule at 2.4 mg (sold as Wegovy) is registered here as an injection for weight management (HSA register), and tirzepatide (sold as Mounjaro) is a different medicine that acts at the GLP-1 receptor and also at the GIP receptor (prescribing information). Wegovy vs Ozempic and Mounjaro vs Ozempic set out how each compares with Ozempic, and Saxenda in Singapore covers liraglutide, a once-daily GLP-1 injection.

Prescribing a diabetes-only product for weight is off-label: a decision only a doctor who has assessed you can make, and one they may decide against. GetLean carries only GLP-1 medications approved by Singapore's Health Sciences Authority, such as Rybelsus, Wegovy and Mounjaro, and whether medication is appropriate for you, and which one, is decided by Dr Quek at your consultation.

Which GLP-1 is best for weight loss?

There is no single best one for everyone: which medicine suits a person, if any does, is decided by the doctor who assesses them. In SURMOUNT-5, a trial that compared tirzepatide with semaglutide directly, 751 adults with obesity and without type 2 diabetes lost 20.2% of their body weight on average on tirzepatide (Mounjaro) and 13.7% on semaglutide (Wegovy) by week 72 (Aronne 2025). The trial was open-label, and individual results vary and are not guaranteed.

Side effects, other health conditions, whether an injection or a tablet suits you, and what is registered here all weigh in. Wegovy vs Mounjaro: which works better? The SURMOUNT-5 head-to-head sets out the trial. That choice is what your consultation with Dr Quek is for, and at every monthly check-in he decides with you whether to continue, adjust or stop.

Who cannot take GLP-1?

Anyone allergic to the medicine or any of its ingredients: hypersensitivity is the formal contraindication in Singapore's registered product information (NDF). The US prescribing information adds a personal or family history of medullary thyroid carcinoma or MEN 2 (prescribing information). It is also stopped in pregnancy: the product information instructs discontinuing when pregnancy is recognised, and for semaglutide, stopping at least two months before a planned pregnancy (pregnancy sections).

A doctor screens for these, and for a wider set of factors, before prescribing. That is exactly what your consultation with Dr Quek is for: nothing is prescribed or dispensed before he has assessed you. Who should not take GLP-1? goes through each one.

How to stop GLP-1?

With the doctor who prescribed it, stepping the dose down rather than stopping it overnight, and never on your own. When the STEP 1 extension stopped semaglutide overnight, the 327 adults followed regained, on average, about two-thirds of their lost weight within a year (Wilding 2022).

At GetLean the programme is designed to end, from day one. The plan for coming off is the GetLean GLP-1 Taper Plan: after hitting your goal weight with the right nutrition and exercise habits built, the dose is stepped down at Dr Quek's monthly reviews towards your lowest effective dose and, where clinically appropriate, off the medication. What is the GetLean GLP-1 Taper Plan? sets out its three stages, and How to come off GLP-1 in Singapore covers stopping and tapering in full. At GetLean, microdosing means taking the medicine below its labelled dose or schedule, and the GetLean GLP-1 Taper Plan gets you there in two ways, and often uses both: GLP-1 microdosing at GetLean, step by step. After the taper, a patient can keep the daily WhatsApp coaching and the monthly reviews with Dr Quek by continuing the monthly subscription, if they wish. If you are choosing a clinic for that process, read which Singapore clinic helps you taper off GLP-1.

When will retatrutide be available in Singapore?

No date has been set. The timetable Lilly has announced names the United States: a Biologics License Application to the FDA in the first quarter of 2027 (Lilly, July 2026). A US decision would not register the medicine here; that is a separate decision by Singapore's Health Sciences Authority. Orforglipron (Foundayo), a daily GLP-1 tablet, is approved in the United States and the United Kingdom but is not registered in Singapore (HSA register; MHRA).

Retatrutide and orforglipron are not registered in Singapore, and GetLean does not prescribe or supply them. GetLean does prescribe and supply HSA-registered GLP-1 medications, after a consultation with Dr Quek. Retatrutide (reta) in Singapore and New weight-loss medicines in Singapore track where each one stands. Two comparisons set out the trial results so far: Is Reta stronger than Mounjaro? for the injections, and Foundayo vs Wegovy pill: which works better? for the tablets.

More questions

Are GLP-1 agonists available in Singapore?

Yes, on a doctor's prescription. The medicines registered in Singapore for weight management include tirzepatide and semaglutide injection (Singapore NDF; Singapore NDF), and every registered semaglutide, tirzepatide and liraglutide product here is classified Prescription Only (HSA register). Tirzepatide is sold here as Mounjaro, and semaglutide for weight management as Wegovy.

How is GLP-1 administered?

By injection, once a week, for the GLP-1 medicines registered here for weight management, which include tirzepatide and semaglutide: they are taken at any time of day, with or without meals (semaglutide label; tirzepatide label). The only GLP-1 tablet on Singapore's register is oral semaglutide (sold as Rybelsus), taken once a day, and its registered indication is type 2 diabetes (Singapore NDF). How and when to take yours comes from your prescriber and the leaflet in your pack.

Can a non-diabetic take GLP-1?

Yes: in Singapore, semaglutide 2.4 mg and tirzepatide are registered for weight management, not only for type 2 diabetes (NDF indications). The registered product information sets that indication at a BMI of 30 or above, or 27 to under 30 with at least one weight-related comorbidity (NDF). GetLean's own criteria answer a different question. Our criteria are a BMI of 25 or more. Anyone can book the first consultation and Dr Quek decides there whether a GLP-1 medication suits you.

What are the common side effects of taking GLP-1 medication?

Nausea, diarrhoea, vomiting and constipation are the most common, and they cluster while the dose is going up. In the pooled trials behind the US semaglutide label, nausea occurred in 44% of treated adults against 16% on placebo (prescribing information); the US tirzepatide label reports nausea in 25 to 29% against 8%, and says most nausea, vomiting and diarrhoea happened during dose escalation and decreased over time (prescribing information). Side effects are why daily contact matters: at GetLean, daily WhatsApp coaching keeps you in touch with our care team (9am to 9pm every day, Singapore time), so anything clinical can reach Dr Quek early, not weeks later. Outside those hours an urgent symptom does not wait for a reply: go to an emergency department, or call 995 if it is an emergency.

Will I regain weight after stopping GLP-1?

Much of it came back in the STEP 1 extension, where the medication was stopped with no taper: the 327 adults followed regained, on average, about two-thirds of their lost weight within a year (Wilding 2022). Stepping down is a different picture: in SURMOUNT-MAINTAIN, adults who stepped down to a lower dose of tirzepatide after 60 weeks were still 16.6% below their starting weight a year later (Horn 2026); individual results vary. That is why the GetLean GLP-1 Taper Plan steps the dose down at Dr Quek's monthly reviews rather than stopping it overnight.

Will health insurance cover GLP-1?

Not under the two Integrated Shield Plan wordings checked, which exclude treatment for obesity and weight reduction (Singlife; Prudential); other insurers have their own wording, so the exclusions section of your own policy is the place to check. As checked on 7 October 2026, obesity is not one of the 23 chronic conditions covered by MediSave's outpatient scheme (MOH), and no GLP-1 medicine for weight is on MOH's list of subsidised drugs or the Healthier SG medication list (MOH; Healthier SG list).

How much is a 3 month supply of GLP-1?

At GetLean you pay month by month: billing is monthly, with the medication included, so three months is three monthly fees at the price for your medication and dose, as listed on this page. The monthly price follows the dose: it can move up when Dr Quek steps the dose up, and back down as he steps it down during the taper.

How much does Mounjaro cost per month in Singapore?

At GetLean, S$488 a month at 2.5 mg and 5 mg, S$788 a month at 7.5 mg and 10 mg, and S$1,088 a month at 15 mg (max dose), all-in: Dr Quek's consultations and reviews, the medication delivered to you, and daily WhatsApp coaching. The first video consultation is S$20, refunded in full if he decides medication is not right for you. The dose, and so the price, is Dr Quek's decision. Mounjaro in Singapore has the table.

How much does Rybelsus cost in Singapore?

At GetLean, S$288 a month at 3 mg and S$388 a month at 7 mg and 14 mg, all-in: Dr Quek's consultations and reviews, the medication delivered to you, and daily WhatsApp coaching. Rybelsus is registered in Singapore for type 2 diabetes only, so prescribing it for weight is off-label and Dr Quek's decision. Rybelsus in Singapore has the table.

Which online GLP-1 program is the best?

The one that answers these questions well for you: who assesses you and whether they are a Singapore-registered doctor, what is included in the price, how dose changes are handled, what happens if you have side effects, and what the plan is for coming off. GetLean's answers are on this page: Dr Quek by live video, one monthly fee with the medication included, dose changes at his monthly reviews, the care team on WhatsApp from 9am to 9pm every day, Singapore time, and the GetLean GLP-1 Taper Plan. How to choose a GLP-1 clinic: nine questions to ask explains why each question matters.

Can you stay on GLP-1 for life?

No rule fixes a number of months, and at GetLean the length is set at Dr Quek's monthly reviews, so staying on for life is not the goal. We work toward your lowest effective dose and, where clinically appropriate, toward coming off the medication entirely, with the habits you have built holding your results. That's what the GetLean GLP-1 Taper Plan is for.

Read next

Book my S$20 consult

Dr Quek confirms suitability at your consultation.

References
  1. Drucker DJ, Mechanisms of Action of GLP-1, Cell Metabolism 2018. pubmed.ncbi.nlm.nih.gov
  2. National Drug Formulary Singapore, registered product information for tirzepatide (SIN17258P). ndf.gov.sg
  3. National Drug Formulary Singapore, registered product information for semaglutide 2.4 mg injection (SIN16748P). ndf.gov.sg
  4. US prescribing information for tirzepatide injection for weight management (DailyMed). dailymed.nlm.nih.gov
  5. Semaglutide 2.4 mg, US prescribing information §2 — administration (DailyMed). dailymed.nlm.nih.gov
  6. Tirzepatide US Prescribing Information and Medication Guide (Eli Lilly), sections 2.1 and 16.2, DailyMed, published 2 September 2026. dailymed.nlm.nih.gov
  7. National Drug Formulary Singapore, registered therapeutic indications for oral semaglutide 3 mg (SIN16215P). ndf.gov.sg
  8. Friedrichsen M et al., semaglutide 2.4 mg, energy intake and gastric emptying, Diabetes Obes Metab 2021. pubmed.ncbi.nlm.nih.gov
  9. Wilding JPH et al., STEP 1, N Engl J Med 2021. pubmed.ncbi.nlm.nih.gov
  10. Jastreboff AM et al., SURMOUNT-1, tirzepatide once weekly for the treatment of obesity, N Engl J Med 2022. pubmed.ncbi.nlm.nih.gov
  11. Health Sciences Authority, Listing of Registered Therapeutic Products (via data.gov.sg). data.gov.sg
  12. Ministry of Health Singapore, parliamentary reply on cases of unauthorised sale of drugs for treatment of diabetes and obesity, 10 September 2024. moh.gov.sg
  13. Healthcare Services (Outpatient Medical Service) Regulations 2023, Singapore Statutes Online, in operation 26 June 2023, last amended with effect from 18 December 2023 (S 840/2023), read 24 October 2026. sso.agc.gov.sg
  14. Ministry of Health, Health Sciences Authority and Singapore Medical Council, Joint Circular No. 87/2024 on regulations and professional standards for telemedicine services and advertisements, 22 November 2024. isomer-user-content.by.gov.sg
  15. Health Products (Therapeutic Products) Regulations 2016, regulation 11 and the definition of a valid prescription. sso.agc.gov.sg
  16. Health Sciences Authority, risks of obtaining prescription medicines and unapproved injectable peptides through unauthorised channels, consumer safety article, 25 September 2026. hsa.gov.sg
  17. Health Sciences Authority, dubious weight loss products sold online can harm your health, consumer safety article (page dated 29 May 2026, migrated from an earlier version of HSA's site). hsa.gov.sg
  18. National Drug Formulary Singapore, registered therapeutic indications for semaglutide injection 1.34 mg/ml (SIN16165P). ndf.gov.sg
  19. Aronne LJ et al., SURMOUNT-5, N Engl J Med 2025;393(1):26-36. pubmed.ncbi.nlm.nih.gov
  20. National Drug Formulary Singapore, product information for the registered semaglutide and tirzepatide products. ndf.gov.sg
  21. Semaglutide 2.4 mg US Prescribing Information — boxed warning (DailyMed). dailymed.nlm.nih.gov
  22. Semaglutide and tirzepatide product information — pregnancy and lactation sections (DailyMed and EMA SmPC). dailymed.nlm.nih.gov
  23. Wilding JPH et al., weight regain after withdrawal of semaglutide, STEP 1 trial extension, Diabetes Obes Metab 2022. pubmed.ncbi.nlm.nih.gov
  24. Horn DB et al., tirzepatide for maintenance of bodyweight reduction in people with obesity (SURMOUNT-MAINTAIN). pubmed.ncbi.nlm.nih.gov
  25. Eli Lilly and Company, TRIUMPH-2 and TRIUMPH-3 phase 3 topline results for retatrutide, press release, 23 July 2026. investor.lilly.com
  26. Health Sciences Authority, Listing of Registered Therapeutic Products (via data.gov.sg), full download read 8 October 2026. data.gov.sg
  27. Medicines and Healthcare products Regulatory Agency, UK first in Europe to authorise orforglipron for weight management and type 2 diabetes, press release, 10 August 2026. gov.uk
  28. Semaglutide 2.4 mg US Prescribing Information — adverse reactions (DailyMed). dailymed.nlm.nih.gov
  29. Tirzepatide US Prescribing Information §6.1, adverse reactions (DailyMed). dailymed.nlm.nih.gov
  30. Singlife, Singlife Shield Policy Contract 2026 (H54.01, 01/04/2026), clause 6. singlife.com
  31. Prudential Singapore, PRUShield Electronic Letter of Guarantee (eLOG) FAQ, question 9. prudential.com.sg
  32. Ministry of Health, Outpatient care (MediSave), last updated 1 June 2026. moh.gov.sg
  33. Ministry of Health, List of subsidised drugs (as of 1 September 2026), last updated 31 August 2026. moh.gov.sg
  34. Ministry of Health, Healthier SG Whitelisted Drugs dataset, data.gov.sg, updated 29 September 2026. data.gov.sg
  35. National Drug Formulary Singapore, registered therapeutic indications (section 4.1) for the semaglutide and tirzepatide products. ndf.gov.sg
  36. National Drug Formulary Singapore, section 4.1 Therapeutic Indications for the registered semaglutide and tirzepatide products. ndf.gov.sg

GLP-1 medication is prescription-only and is dispensed solely where clinically appropriate, as determined by Dr Quek. Clinical-trial figures describe the populations that were studied; individual results vary and are not guaranteed. This page describes how the service works and is not medical advice.

HomeHow it worksPricingAboutOnline clinicComing off GLP-1ResearchContactArticles